ALPHI.PA Facephi Biometria S.A.

Technology Software Euronext Paris
1.69 EUR
Close of Nov 7, 2026
1.48 2.92
Market cap
EUR 44.7M
P/E
-
P/B
2.90x
ROE
1.7%
Dividend yield
-
Fundamental score
2.0/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ALPHI.PA undervalued?

Graham number

The Graham number of Facephi Biometria S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Facephi Biometria S.A. fundamental analysis

7 of 11 checks passed

ROE 1/2

ROE in an average range (9.25%) suggests satisfactory profitability and decent utilization of shareholders' equity.

ROA 1/2

The stock's ROA (4.49%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

PBV 1/2

The stock's PBV ratio (2.84x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

DER 1/2

The stock has a reasonable amount of debt compared to its ownership (51%), suggesting a balanced financial position and a moderate level of risk.

Revenue Growth 1/2

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

Net Profit Growth 1/2

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

Assets Growth 2/2

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

Graham Number 0/1

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

Dividend Growth 0/2

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Dividend 0/2

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Buffet Intrinsic Value 0/1

Based on Warren Buffett's formula, the company's stock seems overpriced (-23), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Facephi Biometria S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Facephi Biometria S.A.

Facephi Biometria, S.A. engages in the biometric facial recognition technology solutions in Spain and internationally. The company offers authentication, a solution allows user to authenticate through multibiometric technology and prevents unauthorized access; onboarding, a solution that allows to verify the identity of users remotely, automatically capturing the document information, and taking a selfie with passive liveness; and digital identity platform, that allows the c…

Full company profile